“The world doesn’t need more apps [to control diabetes]. It needs companies that understand the disease to lead." Novo is currently conducting a study of its digital insulin pen in ...

You'll also find brand names used in india and internationally ... a new approach to managing type 2 diabetes, showing improvements in weight loss and insulin production. Anti-diabetic Drug ...

The drug is used to treat type 2 diabetes and obesity and it works by mimicking the effects of the body’s natural hormone, ...

There's no doubt that being a child star is difficult, and these actors left the industry behind to pursue other ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

After years of preparation, Eli Lilly is on the brink of launching a fully connected and personalised diabetes management ... brings together a pre-filled insulin pen, the TempoSmart app and ...

Nov. 7, 2024 — People who work the nightshift or odd hours and eat at irregular times are more prone to weight gain and diabetes, likely due to eating patterns not timed with natural daylight ...